-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60

Benzinga·10/19/2026 14:37:27
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $55 to $60.